Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 2/3 2Phase 1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Renal Pelvis and Ureter Urothelial Carcinoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1

Interventions

Cisplatin 12Magnetic Resonance Spectroscopy 10Specimen Handling 9Gemcitabine 9Carboplatin 9pembrolizumab 8Pemetrexed 8atezolizumab 7Radiotherapy, Intensity-Modulated 5Platinum 5Paclitaxel 5Nivolumab 5Immunoglobulin G 5Doxorubicin 5Docetaxel 5Disulfides 5Bevacizumab 5130-nm albumin-bound paclitaxel 51,2-diaminocyclohexaneplatinum II citrate 5Cetuximab 4Biopsy 4Temozolomide 3Rituximab 3Dexamethasone 3(225)Ac-DOTA-c(RGDyK) 3venetoclax 2pegfilgrastim 2merphos 2liposomal doxorubicin 2durvalumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × pegfilgrastim × 30 days × Clear all
NCT04628767 2026-06-03

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2/3 Recruiting
131 enrolled
Genitourinary

Renal Pelvis and Ureter Urothelial Carcinoma

NCT01046825 2026-06-02

Mature B-Cell Lymphoma And Leukemia Study III

St. Jude Children's Research Hospital

Phase 2/3 Active not recruiting
128 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡